Arrhythmogenic effects of acute electronic cigarette compared to tobacco cigarette smoking in people living with HIV
Physiological Reports · 2024
DOI: 10.14814/phy2.16158 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Physiological Reports, 2024. Verfasst von Isabelle Ruedisueli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology, UCLA David Geffen School of Medicine, Los Angeles, California, USA. Hauptthemen laut MEDLINE: HIV Infections, Electronic Nicotine Delivery Systems, Cigarette Smoking, Heart Rate. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Sandler Foundation, NIH National Center for Advancing Translational Science, NCATS NIH HHS.
Abstract (Originalsprache)
The leading cause of death in people living with HIV (PLWH) is cardiovascular disease, and the high prevalence of tobacco cigarette (TC) smoking is a major contributor. Switching to electronic cigarettes (ECs) has been promoted as a harm reduction strategy. We sought to determine if acute EC compared to TC smoking had less harmful effects on arrhythmogenic risk factors including acute changes in hemodynamics, heart rate variability (HRV), and ventricular repolarization (VR). In PLWH who smoke, changes in hemodynamics, HRV, and VR were compared pre/post acutely using an EC, TC, or puffing on an empty straw on different days in random order, in a crossover study. Thirty‐seven PLWH (36 males, mean age 40.5 ± 9.1 years) participated. Plasma nicotine was greater after TC versus EC use (10.12 ± 0.96 vs. 6.18 ± 0.99 ng/mL, respectively, p = 0.004). HR increased significantly, and similarly, after acute EC and TC smoking compared to control. Changes in HRV that confer increased cardiac risk (LF/HF ratio) were significantly smaller after acute EC versus TC use, consistent with a harm reduction effect. In a post‐hoc analysis of PLWH with and without positive concurrent recreational drug use as indicated by point of care urine toxicology testing, this differential effect was only seen in PLWH not currently using recreational drugs. Changes in VR were not different among the three exposures. In PLWH who smoke, EC compared to TC smoking resulted in smaller adverse changes in HRV. This differential effect was accompanied by a smaller increase in plasma nicotine, and was negated by concurrent recreational drug use. Additional studies are warranted in this vulnerable population disproportionately affected by tobacco‐related health disparities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Cardiology, UCLA David Geffen School of Medicine, Los Angeles, California, USA.
- Departments of Medicine and Computational Medicine, UCLA David Geffen School of Medicine, Los Angeles, California, USA.
ORCID-Profile: Holly R Middlekauff
Förderung
- The Sandler Foundation
- NIH National Center for Advancing Translational Science
- NCATS NIH HHS
- Tobacco Related Disease Research Program
- UCLA-CDU CFAR Clinical Sciences Core and the UCLA-CDU CFAR grant
- NIAID NIH HHS
Zitieren
APA
Ruedisueli, I., Shi, K., Lopez, S., Gornbein, J., & Middlekauff, H. R. (2024). Arrhythmogenic effects of acute electronic cigarette compared to tobacco cigarette smoking in people living with HIV. Physiological Reports. https://doi.org/10.14814/phy2.16158
Vancouver
Ruedisueli I, Shi K, Lopez S, Gornbein J, Middlekauff HR. Arrhythmogenic effects of acute electronic cigarette compared to tobacco cigarette smoking in people living with HIV. Physiological Reports. 2024. doi:10.14814/phy2.16158
BibTeX
@article{Ruedisueli2024,
author = {Ruedisueli, Isabelle and Shi, Katie and Lopez, Samuel and Gornbein, Jeffrey and Middlekauff, Holly R},
title = {Arrhythmogenic effects of acute electronic cigarette compared to tobacco cigarette smoking in people living with HIV},
journal = {Physiological Reports},
year = {2024},
doi = {10.14814/phy2.16158}
}
EUVIMED